Show
Sort by
-
Olmesartan induced weight loss and small vessel vasculitis
-
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon : a Belgian experience
-
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs
-
HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster
-
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients
-
Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naive or relapsing chronic hepatitis C patients
-
The management of patients with mild hepatitis C
-
Lymphocytic colitis: a distinct clinical entity?: a clinicopathological confrontation of lymphocytic and collagenous colitis